Enzo-logo-750-500.jpg
Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
June 15, 2021 12:00 ET | Enzo Biochem, Inc.
Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Third Quarter Fiscal 2021 Results
June 09, 2021 16:05 ET | Enzo Biochem, Inc.
Total third quarter revenue of $32.8 million, a record quarterly high, increased 94% year-over-year Consolidated quarterly gross margin was 49% versus 26% in the previous year period, confirming...
Enzo-logo-750-500.jpg
Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
June 01, 2021 16:05 ET | Enzo Biochem, Inc.
NEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results...
Enzo-logo-750-500.jpg
Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
April 21, 2021 08:00 ET | Enzo Biochem, Inc.
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used with PCR based molecular diagnostic or antigen-based testing platforms ...
Enzo-logo-750-500.jpg
ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
March 17, 2021 16:15 ET | Enzo Biochem, Inc.
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
March 15, 2021 16:05 ET | Enzo Biochem, Inc.
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion from impact of COVID-19 pandemicSecond quarter clinical laboratory revenue of $24.0...
Enzo-logo-750-500.jpg
Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
March 04, 2021 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, March 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present...
Enzo-logo-750-500.jpg
Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
March 02, 2021 08:00 ET | Enzo Biochem, Inc.
Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results Company also publishes new corporate white...
Enzo-logo-750-500.jpg
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
March 01, 2021 16:05 ET | Enzo Biochem, Inc.
NEW YORK, NY, March 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that it will report second...
Enzo-logo-750-500.jpg
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
February 03, 2021 08:30 ET | Enzo Biochem, Inc.
NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the recent issuance of U.S....